GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands.
摘要：
The main inhibitory neurotransmitter receptor of the brain, the -aminobutyric acid type A receptor (GABAA), mediates the actions of several classes of clinically important drugs, such as benzodiazepines, barbiturates and general anaesthetics. This review summarizes the current knowledge on how classical benzodiazepines and novel nonbenzodiazepine compounds act on the benzodiazepine site of GABAA receptors and on their clinical pharmacology related to anxiolytic, sedative, hypnotic and cognitive effects or side-effects. Partial agonism, receptor subtype selectivity and novel binding sites are discussed as possible strategies to develop new drugs with fewer adverse effects than are seen in the clinical use of benzodiazepines.
展开
DOI：
10.3109/07853899708999348
被引量：
年份：
1997
相似文献
参考文献
引证文献
来源期刊
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
